The simple task of recording the frequency and severity of post chemo nausea and vomiting allowed clinical staff to make adjustments to patients’ antiemetic therapy, researchers led by Frida Barak, MD, of Barzilai Medical Center Ashkelon, Israel report.
"Asking patients to track their nausea and vomiting after a course of chemotherapy helped the health care team to adjust medications and achieve better control of symptoms, according to the results of a small single center study."
"Overall, antiemetic therapy was successful after the first treatment, with 57% of patients not experiencing any nausea or vomiting."
“The results of the current study suggest a propensity (1.5 times higher) for women who experienced nausea/vomiting during pregnancy to experience chemotherapy induced nausea/vomiting,” the researchers wrote. “The knowledge of patient nausea/vomiting during pregnancy, motion sickness related nausea/vomiting, or past personal experience or exposure to nausea/vomiting in others are of major importance for nurses and other clinical staff because they possibly identify patients who could experience nausea/vomiting during chemotherapy.”